The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
Rheumatoid Arthritis Awareness Day 2025 falls on February 2 to raise awareness around the chronic autoimmune disease.
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...